{"transactions":[{"id":4616524,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2026-09-12T00:10:47.000Z","date":"2026-09-10","kind":"grant","planned":false,"acquired":true,"shares":732500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option granted pursuant to the Tenaya Therapeutics, Inc. Amended and Restated 2021 Equity Incentive Plan. Option will vest as to 1/48th of the total number of shares subject to the option on the one month anniversary of the Transaction Date and 1/48th of the total number of shares subject to the option on each monthly anniversary thereafter until fully vested."}],"balance_after":732500,"derivative":{"exercise_price":0.6488,"exercise_date":"2026-10-10","expiration_date":"2036-09-09","underlying":"Common Stock","underlying_shares":732500},"source":{"system":"sec-edgar","filing":"0001193125-26-389563","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000119312526389563/ownership.xml","form_type":"4"}},{"id":4616523,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-12T00:10:47.000Z","date":"2026-09-10","kind":"grant","planned":false,"acquired":true,"shares":122000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Tenaya Therapeutics, Inc. common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Tenaya Therapeutics, Inc. Amended and Restated 2021 Equity Incentive Plan. The restricted stock units will vest as to 1/8th of the total number of shares subject to the restricted stock unit award on February 15, 2027, and 1/8th of the total number of shares subject to the restricted stock unit award every six months thereafter until fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 384,069 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":539782,"source":{"system":"sec-edgar","filing":"0001193125-26-389563","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000119312526389563/ownership.xml","form_type":"4"}},{"id":685486,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-18T00:50:17.000Z","date":"2026-08-17","kind":"sale","planned":false,"acquired":false,"shares":7406,"price":0.7097,"value":5256.0382,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 3, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $.6820 to $.7253. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F9","text":"Includes 262,069 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":417782,"source":{"system":"sec-edgar","filing":"0001193125-26-354518","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000119312526354518/ownership.xml","form_type":"4"}},{"id":685485,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-18T00:50:17.000Z","date":"2026-08-17","kind":"sale","planned":false,"acquired":false,"shares":5020,"price":0.7097,"value":3562.694,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 6, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $.6820 to $.7253. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Includes 281,894 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":425188,"source":{"system":"sec-edgar","filing":"0001193125-26-354518","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000119312526354518/ownership.xml","form_type":"4"}},{"id":685484,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-18T00:50:17.000Z","date":"2026-08-17","kind":"sale","planned":false,"acquired":false,"shares":3969,"price":0.7098,"value":2817.1962,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 23, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $.6820 to $.7253. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 295,331 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":430208,"source":{"system":"sec-edgar","filing":"0001193125-26-354518","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000119312526354518/ownership.xml","form_type":"4"}},{"id":685483,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-18T00:50:17.000Z","date":"2026-08-17","kind":"sale","planned":false,"acquired":false,"shares":5837,"price":0.7097,"value":4142.5189,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $.6820 to $.7253. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 305,956 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":434177,"source":{"system":"sec-edgar","filing":"0001193125-26-354518","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000119312526354518/ownership.xml","form_type":"4"}},{"id":772036,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-19T23:09:59.000Z","date":"2026-05-18","kind":"sale","planned":false,"acquired":false,"shares":3390,"price":0.7934,"value":2689.626,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 6, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 321,581 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":440014,"source":{"system":"sec-edgar","filing":"0001193125-26-231324","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000119312526231324/ownership.xml","form_type":"4"}},{"id":900995,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-02-18T00:14:17.000Z","date":"2026-02-17","kind":"sale","planned":false,"acquired":false,"shares":5032,"price":0.643,"value":3235.576,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 6, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $0.6075 to $0.671. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Includes 330,187 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":443404,"source":{"system":"sec-edgar","filing":"0001193125-26-055442","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000119312526055442/ownership.xml","form_type":"4"}},{"id":900994,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-02-18T00:14:17.000Z","date":"2026-02-17","kind":"sale","planned":false,"acquired":false,"shares":3979,"price":0.6431,"value":2558.8949,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 23, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $0.6075 to $0.671. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 343,625 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":448436,"source":{"system":"sec-edgar","filing":"0001193125-26-055442","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000119312526055442/ownership.xml","form_type":"4"}},{"id":900993,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-02-18T00:14:17.000Z","date":"2026-02-17","kind":"sale","planned":false,"acquired":false,"shares":5851,"price":0.643,"value":3762.193,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $0.6075 to $0.671. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 354,250 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":452415,"source":{"system":"sec-edgar","filing":"0001193125-26-055442","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000119312526055442/ownership.xml","form_type":"4"}},{"id":917718,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2026-02-05T23:02:09.000Z","date":"2026-02-03","kind":"grant","planned":false,"acquired":true,"shares":952250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest as to 1/48th of the total number of shares subject to the option on the one month anniversary of the Transaction Date and 1/48th of the total number of shares subject to the option on each monthly anniversary thereafter until fully vested."}],"balance_after":952250,"derivative":{"exercise_price":0.915,"exercise_date":"2026-03-03","expiration_date":"2036-02-02","underlying":"Common Stock","underlying_shares":952250},"source":{"system":"sec-edgar","filing":"0001193125-26-039760","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000119312526039760/ownership.xml","form_type":"4"}},{"id":917717,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-02-05T23:02:09.000Z","date":"2026-02-03","kind":"grant","planned":false,"acquired":true,"shares":158600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Tenaya Therapeutics, Inc. common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. The restricted stock units will vest as to 1/8th of the total number of shares subject to the restricted stock unit award on August 15, 2026, and 1/8th of the total number of shares subject to the restricted stock unit award every six months thereafter until fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 369,875 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":458266,"source":{"system":"sec-edgar","filing":"0001193125-26-039760","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000119312526039760/ownership.xml","form_type":"4"}},{"id":997741,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-11-18T01:33:38.000Z","date":"2025-11-17","kind":"sale","planned":false,"acquired":false,"shares":3126,"price":1.33,"value":4157.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 6, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 211,275 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":299666,"source":{"system":"sec-edgar","filing":"0001193125-25-284996","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000119312525284996/ownership.xml","form_type":"4"}},{"id":1063912,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-08-19T00:58:29.000Z","date":"2025-08-18","kind":"sale","planned":false,"acquired":false,"shares":4920,"price":1.253,"value":6164.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 6, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.18 to $1.32. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Includes 219,881 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":302792,"source":{"system":"sec-edgar","filing":"0001667937-25-000006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000166793725000006/ownership.xml","form_type":"4"}},{"id":1063911,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-08-19T00:58:29.000Z","date":"2025-08-18","kind":"sale","planned":false,"acquired":false,"shares":3893,"price":1.253,"value":4877.929,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 23, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.18 to $1.32. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 233,318 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":307712,"source":{"system":"sec-edgar","filing":"0001667937-25-000006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000166793725000006/ownership.xml","form_type":"4"}},{"id":1063910,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-08-19T00:58:29.000Z","date":"2025-08-18","kind":"sale","planned":false,"acquired":false,"shares":5720,"price":1.253,"value":7167.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.18 to $1.32. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 243,943 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":311605,"source":{"system":"sec-edgar","filing":"0001667937-25-000006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000166793725000006/ownership.xml","form_type":"4"}},{"id":1145374,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-05-16T23:07:01.000Z","date":"2025-05-16","kind":"sale","planned":false,"acquired":false,"shares":3189,"price":0.4427,"value":1411.7703,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 6, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 259,568 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":317325,"source":{"system":"sec-edgar","filing":"0000950170-25-073823","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000095017025073823/ownership.xml","form_type":"4"}},{"id":1215058,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-03-11T01:42:17.000Z","date":"2025-03-10","kind":"sale","planned":false,"acquired":false,"shares":3947,"price":0.5384,"value":2125.0648,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 23, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $0.5080 to $0.5846. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 268,174 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":320514,"source":{"system":"sec-edgar","filing":"0000950170-25-036770","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000095017025036770/ownership.xml","form_type":"4"}},{"id":1215057,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-03-11T01:42:17.000Z","date":"2025-03-10","kind":"sale","planned":false,"acquired":false,"shares":5794,"price":0.5384,"value":3119.4896,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $0.5080 to $0.5846. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 278,799 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":324461,"source":{"system":"sec-edgar","filing":"0000950170-25-036770","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000095017025036770/ownership.xml","form_type":"4"}},{"id":1278758,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-08T01:29:29.000Z","date":"2025-02-06","kind":"grant","planned":false,"acquired":true,"shares":401390,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on February 6, 2025 (the \"Effective Date\"). The Option Repricing applies to nonstatutory options with exercise prices greater than $5.25 per share held by Reporting Person as of the Effective Date."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Pursuant to the Option Repricing, the exercise price of the repriced options, including the reported option, has been amended to reduce the exercise price to $1.21 per share. However, if the Reporting Person exercises a repriced option before the end of a \"Retention Period\" that begins on the Effective Date of the Option Repricing and ends on the earliest to occur of the following: (i) July 24, 2025 or (ii) a Change in Control, as defined in the Issuer's 2021 Equity Incentive Plan, then the Reporting Person will be required to pay a premium exercise price that is equal to the original exercise price per share of such option. There was no change to the vesting schedules, expiration dates or number of shares underlying the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"1/48th of the shares underying the option vested on March 15, 2022, and the remaining shares vest in 48 equal monthly installments thereafter."}],"balance_after":401390,"derivative":{"exercise_price":1.21,"exercise_date":"2022-03-15","expiration_date":"2032-02-14","underlying":"Common Stock","underlying_shares":401390},"source":{"system":"sec-edgar","filing":"0000950170-25-016582","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000095017025016582/ownership.xml","form_type":"4"}},{"id":1278757,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-08T01:29:29.000Z","date":"2025-02-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":401390,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on February 6, 2025 (the \"Effective Date\"). The Option Repricing applies to nonstatutory options with exercise prices greater than $5.25 per share held by Reporting Person as of the Effective Date."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Pursuant to the Option Repricing, the exercise price of the repriced options, including the reported option, has been amended to reduce the exercise price to $1.21 per share. However, if the Reporting Person exercises a repriced option before the end of a \"Retention Period\" that begins on the Effective Date of the Option Repricing and ends on the earliest to occur of the following: (i) July 24, 2025 or (ii) a Change in Control, as defined in the Issuer's 2021 Equity Incentive Plan, then the Reporting Person will be required to pay a premium exercise price that is equal to the original exercise price per share of such option. There was no change to the vesting schedules, expiration dates or number of shares underlying the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"1/48th of the shares underying the option vested on March 15, 2022, and the remaining shares vest in 48 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":15.19,"exercise_date":"2022-03-15","expiration_date":"2032-02-14","underlying":"Common Stock","underlying_shares":401390},"source":{"system":"sec-edgar","filing":"0000950170-25-016582","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000095017025016582/ownership.xml","form_type":"4"}},{"id":1278756,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-08T01:29:29.000Z","date":"2025-02-06","kind":"grant","planned":false,"acquired":true,"shares":161214,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on February 6, 2025 (the \"Effective Date\"). The Option Repricing applies to nonstatutory options with exercise prices greater than $5.25 per share held by Reporting Person as of the Effective Date."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Pursuant to the Option Repricing, the exercise price of the repriced options, including the reported option, has been amended to reduce the exercise price to $1.21 per share. However, if the Reporting Person exercises a repriced option before the end of a \"Retention Period\" that begins on the Effective Date of the Option Repricing and ends on the earliest to occur of the following: (i) July 24, 2025 or (ii) a Change in Control, as defined in the Issuer's 2021 Equity Incentive Plan, then the Reporting Person will be required to pay a premium exercise price that is equal to the original exercise price per share of such option. There was no change to the vesting schedules, expiration dates or number of shares underlying the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"1/48th of the shares underying the option vested on July 17, 2021, and the remaining shares vest in 48 equal monthly installments thereafter."}],"balance_after":161214,"derivative":{"exercise_price":1.21,"exercise_date":"2021-07-17","expiration_date":"2031-06-16","underlying":"Common Stock","underlying_shares":161214},"source":{"system":"sec-edgar","filing":"0000950170-25-016582","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000095017025016582/ownership.xml","form_type":"4"}},{"id":1278755,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-08T01:29:29.000Z","date":"2025-02-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":161214,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on February 6, 2025 (the \"Effective Date\"). The Option Repricing applies to nonstatutory options with exercise prices greater than $5.25 per share held by Reporting Person as of the Effective Date."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Pursuant to the Option Repricing, the exercise price of the repriced options, including the reported option, has been amended to reduce the exercise price to $1.21 per share. However, if the Reporting Person exercises a repriced option before the end of a \"Retention Period\" that begins on the Effective Date of the Option Repricing and ends on the earliest to occur of the following: (i) July 24, 2025 or (ii) a Change in Control, as defined in the Issuer's 2021 Equity Incentive Plan, then the Reporting Person will be required to pay a premium exercise price that is equal to the original exercise price per share of such option. There was no change to the vesting schedules, expiration dates or number of shares underlying the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"1/48th of the shares underying the option vested on July 17, 2021, and the remaining shares vest in 48 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":9.36,"exercise_date":"2021-07-17","expiration_date":"2031-06-16","underlying":"Common Stock","underlying_shares":161214},"source":{"system":"sec-edgar","filing":"0000950170-25-016582","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000095017025016582/ownership.xml","form_type":"4"}},{"id":1278754,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-08T01:29:29.000Z","date":"2025-02-06","kind":"grant","planned":false,"acquired":true,"shares":353271,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on February 6, 2025 (the \"Effective Date\"). The Option Repricing applies to nonstatutory options with exercise prices greater than $5.25 per share held by Reporting Person as of the Effective Date."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Pursuant to the Option Repricing, the exercise price of the repriced options, including the reported option, has been amended to reduce the exercise price to $1.21 per share. However, if the Reporting Person exercises a repriced option before the end of a \"Retention Period\" that begins on the Effective Date of the Option Repricing and ends on the earliest to occur of the following: (i) July 24, 2025 or (ii) a Change in Control, as defined in the Issuer's 2021 Equity Incentive Plan, then the Reporting Person will be required to pay a premium exercise price that is equal to the original exercise price per share of such option. There was no change to the vesting schedules, expiration dates or number of shares underlying the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The shares underlying the option are fully vested and exercisable."}],"balance_after":353271,"derivative":{"exercise_price":1.21,"exercise_date":"2021-03-27","expiration_date":"2031-02-26","underlying":"Common Stock","underlying_shares":353271},"source":{"system":"sec-edgar","filing":"0000950170-25-016582","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000095017025016582/ownership.xml","form_type":"4"}},{"id":1278753,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-08T01:29:29.000Z","date":"2025-02-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":353271,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on February 6, 2025 (the \"Effective Date\"). The Option Repricing applies to nonstatutory options with exercise prices greater than $5.25 per share held by Reporting Person as of the Effective Date."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Pursuant to the Option Repricing, the exercise price of the repriced options, including the reported option, has been amended to reduce the exercise price to $1.21 per share. However, if the Reporting Person exercises a repriced option before the end of a \"Retention Period\" that begins on the Effective Date of the Option Repricing and ends on the earliest to occur of the following: (i) July 24, 2025 or (ii) a Change in Control, as defined in the Issuer's 2021 Equity Incentive Plan, then the Reporting Person will be required to pay a premium exercise price that is equal to the original exercise price per share of such option. There was no change to the vesting schedules, expiration dates or number of shares underlying the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The shares underlying the option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":5.64,"exercise_date":"2021-03-27","expiration_date":"2031-02-26","underlying":"Common Stock","underlying_shares":353271},"source":{"system":"sec-edgar","filing":"0000950170-25-016582","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000095017025016582/ownership.xml","form_type":"4"}},{"id":1278752,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2025-02-08T01:29:29.000Z","date":"2025-02-06","kind":"grant","planned":false,"acquired":true,"shares":650000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest as to 1/48th of the total number of shares subject to the option on the one month anniversary of the Transaction Date and 1/48th of the total number of shares subject to the option on each monthly anniversary thereafter until fully vested."}],"balance_after":650000,"derivative":{"exercise_price":1,"exercise_date":"2025-03-06","expiration_date":"2035-03-05","underlying":"Common Stock","underlying_shares":650000},"source":{"system":"sec-edgar","filing":"0000950170-25-016582","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000095017025016582/ownership.xml","form_type":"4"}},{"id":1278751,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-02-08T01:29:29.000Z","date":"2025-02-06","kind":"grant","planned":false,"acquired":true,"shares":34424,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Tenaya Therapeutics, Inc. common stock."},{"field":"date","element":"transactionDate","label":"F4","text":"The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. The restricted stock units will vest as to 1/4th of the total number of shares subject to the restricted stock unit award on May 15, 2025, and 1/4th of the total number of shares subject to the restricted stock unit award every six months thereafter until fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 294,424 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":330255,"source":{"system":"sec-edgar","filing":"0000950170-25-016582","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000095017025016582/ownership.xml","form_type":"4"}},{"id":1278750,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-02-08T01:29:29.000Z","date":"2025-02-06","kind":"grant","planned":false,"acquired":true,"shares":107500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Tenaya Therapeutics, Inc. common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. The restricted stock units will vest as to 1/8th of the total number of shares subject to the restricted stock unit award on August 15, 2025, and 1/8th of the total number of shares subject to the restricted stock unit award every six months thereafter until fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 260,000 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":295831,"source":{"system":"sec-edgar","filing":"0000950170-25-016582","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000095017025016582/ownership.xml","form_type":"4"}},{"id":1431361,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-08-17T00:25:47.000Z","date":"2024-08-16","kind":"sale","planned":false,"acquired":false,"shares":3946,"price":2.8945,"value":11421.697,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 23, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $2.79 to $3.02. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 152,500 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":188331,"source":{"system":"sec-edgar","filing":"0000950170-24-098234","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000095017024098234/ownership.xml","form_type":"4"}},{"id":1431360,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-08-17T00:25:47.000Z","date":"2024-08-16","kind":"sale","planned":false,"acquired":false,"shares":5802,"price":2.8945,"value":16793.889,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $2.79 to $3.02. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 152,500 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":192277,"source":{"system":"sec-edgar","filing":"0000950170-24-098234","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000095017024098234/ownership.xml","form_type":"4"}},{"id":1615834,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2024-02-28T00:28:39.000Z","date":"2024-02-23","kind":"grant","planned":false,"acquired":true,"shares":505000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest as to 1/48th of the total number of shares subject to the option on the one month anniversary of the Transaction Date and 1/48th of the total number of shares subject to the option on each monthly anniversary thereafter until fully vested."}],"balance_after":505000,"derivative":{"exercise_price":5.22,"exercise_date":"2024-03-23","expiration_date":"2034-02-22","underlying":"Common Stock","underlying_shares":505000},"source":{"system":"sec-edgar","filing":"0000950170-24-021546","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000095017024021546/ownership.xml","form_type":"4"}},{"id":1615833,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-02-28T00:28:39.000Z","date":"2024-02-23","kind":"grant","planned":false,"acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Tenaya Therapeutics, Inc. common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. The restricted stock units will vest as to 1/8th of the total number of shares subject to the restricted stock unit award on August 15, 2024, and 1/8th of the total number of shares subject to the restricted stock unit award every six months thereafter until fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 178,750 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":198079,"source":{"system":"sec-edgar","filing":"0000950170-24-021546","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000095017024021546/ownership.xml","form_type":"4"}},{"id":1638266,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-02-17T01:30:04.000Z","date":"2024-02-16","kind":"sale","planned":false,"acquired":false,"shares":6358,"price":5.86,"value":37257.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $5.61 to $6.15. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 93,750 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":113079,"source":{"system":"sec-edgar","filing":"0000950170-24-016664","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000095017024016664/ownership.xml","form_type":"4"}},{"id":1801883,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-08-18T22:31:08.000Z","date":"2023-08-16","kind":"sale","planned":false,"acquired":false,"shares":5563,"price":3.81,"value":21195.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $3.76 to $3.87. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 109,375 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":119437,"source":{"system":"sec-edgar","filing":"0001209191-23-046639","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000120919123046639/doc4.xml","form_type":"4"}},{"id":2007658,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2023-02-17T23:43:51.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":675000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest as to 1/48th of the total number of shares subject to the option on the one month anniversary of the Transaction Date and 1/48th of the total number of shares subject to the option on each monthly anniversary thereafter until fully vested."}],"balance_after":675000,"derivative":{"exercise_price":3.06,"exercise_date":"2023-03-15","expiration_date":"2033-02-14","underlying":"Common Stock","underlying_shares":675000},"source":{"system":"sec-edgar","filing":"0001209191-23-010880","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000120919123010880/doc4.xml","form_type":"4"}},{"id":2007657,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-02-17T23:43:51.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Tenaya Therapeutics, Inc. common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. The restricted stock units will vest as to 1/8th of the total number of shares subject to the restricted stock unit award on the six month anniversary of the Transaction Date, and 1/8th of the total number of shares subject to the restricted stock unit award every six months thereafter until fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 125,000 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":125000,"source":{"system":"sec-edgar","filing":"0001209191-23-010880","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000120919123010880/doc4.xml","form_type":"4"}},{"id":2388517,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2022-02-17T22:45:26.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":401390,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest as to 1/48th of the total number of shares subject to the option on the one (1) month anniversary of the Transaction Date and 1/48th of the total number of shares subject to the option on each monthly anniversary thereafter, subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date."}],"balance_after":401390,"derivative":{"exercise_price":15.19,"exercise_date":"2022-03-15","expiration_date":"2032-02-14","underlying":"Common Stock","underlying_shares":401390},"source":{"system":"sec-edgar","filing":"0001209191-22-010925","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000120919122010925/doc4.xml","form_type":"4"}},{"id":4496534,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-01-06T22:01:21.000Z","date":"2017-01-04","kind":"grant","acquired":true,"shares":25200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following 1/4/2018 while the optionee provides continuous service to the Issuer."}],"balance_after":25200,"derivative":{"exercise_price":19.5,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":25200},"source":{"system":"sec-edgar","filing":"0000899243-17-000698","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000089924317000698/doc4.xml","form_type":"4"}}]}